
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Alousi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2002 - 2005
Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine/Pediatrics, 1997 - 2001
Wayne State University School of MedicineClass of 1997
Certifications & Licensure
FL State Medical License 2021 - Present
GA State Medical License 2023 - 2027
TX State Medical License 2006 - 2027
AZ State Medical License 2023 - 2026
LA State Medical License 2023 - 2026
MS State Medical License 2023 - 2026
OK State Medical License 2020 - 2026
American Board of Internal Medicine Hematology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013, 2015
Clinical Trials
- Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302) Start of enrollment: 2005 Sep 01
- Thymoglobulin (ATG) Dose Finding Study Start of enrollment: 2006 Dec 01
- Initial Systemic Treatment of Acute GVHD: A Phase II Randomized Trial Evaluating Etanercept, Mycophenolate Mofetil (MMF), Denileukin Diftitox (Ontak), and Pentostatin in Combination With Corticosteroids Start of enrollment: 2005 Aug 01
Publications & Presentations
PubMed
- Fecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD.Christopher Fan, Tomo Hayase, Chia-Chi Chang, Israel K Glover, Ivonne I Flores
Blood Advances. 2026-01-20 - Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single...Betül Oran, Peter Thall, Amin Alousi, Gheath Al-Atrash, Rohtesh Mehta
Haematologica. 2026-01-01 - Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity.Ioannis Evangelos Louloudis, Yi-Bin Chen, Nikolaos Spyrou, Amin Alousi, Nikolaos Katsivelos
Transplantation and Cellular Therapy. 2026-01-01
Journal Articles
- Pilot Study Using Post-Transplant Cyclophosphamide (PTCy), Tacrolimus and Mycophenolate GVHD Prophylaxis for Older Patients Receiving 10/10 HLA-Matched Unrelated Donor...Uday R Popat, Amin Alousi, Issa F Khouri, Muzaffar Qazilbash, Richard E Champlin, Partow Kebriaei, Simrit Parmar, Chitra Hosing, Nature
- Impact of a Novel Prognostic Model, Hematopoietic Cell Transplant-Composite Risk (HCT-CR), on Allogeneic Transplant Outcomes in Patients with Acute Myeloid Leukemia an...Uday Popat, Chitra M Hosing, Issa Khouri, Richard Champlin, Simrit Parmar, Partow Kebriaei, Borje S Andersson, Qaiser Bashir, Amin Alousi, Nature
- A Phase II/III Randomized, Multicenter Trial of Prednisone /Sirolimus vs Prednisone/Sirolimus/Calcineurin Inhibitor for Treatment of Chronic Graft-Versus-Host Disease:...Amin M Alousi, Mukta Arora, Luciano J Costa, Aleksandr Lazaryan, Daniel J Weisdorf, Sunil Abhyankar, Eneida R Nemecek, Haematologica
Abstracts/Posters
- Blinatumomab Is Well Tolerated Maintenance Therapy Following Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic LeukemiaAmin M. Alousi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Allogeneic Hematopoietic Cell Transplantation May Improve Long-Term Outcomes in Patients with Ph-like Acute Lymphoblastic Leukemia with CRLF2 OverexpressionAmin M. Alousi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Donor Clonal Hematopoiesis Increases Risk of Acute Graft Versus Host Disease after Matched Related Transplantation in AML and MDS PatientsAmin M. Alousi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Your Stem Cell Transplant Consultation: Questions to AskJanuary 31st, 2025
Understanding Stem Cell TransplantsJanuary 13th, 2025
5 Things I Learned from My Non-Hodgkin’s Lymphoma TreatmentMay 14th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:













